We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROP icon
301
Roper Technologies
ROP
$37.5B
$4.45M 0.07%
16,705
-136
-0.8% -$38.5K
SPGI icon
302
S&P Global
SPGI
$130B
$4.42M 0.07%
25,987
+217
+0.8% +$38.9K
PNC icon
303
PNC Financial Services
PNC
$99.8B
$4.4M 0.07%
37,628
-1,658
-4% -$212K
ENTA icon
304
Enanta Pharmaceuticals
ENTA
$373M
$4.39M 0.07%
+62,000
New +$4.75M
OKE icon
305
Oneok
OKE
$57.1B
$4.38M 0.07%
81,170
+6,874
+9% +$427K
SWK icon
306
Stanley Black & Decker
SWK
$14.4B
$4.37M 0.07%
36,469
+2,630
+8% +$328K
SPG icon
307
Simon Property Group
SPG
$74.6B
$4.33M 0.07%
25,798
+1,510
+6% +$270K
HPQ icon
308
HP
HPQ
$24.2B
$4.31M 0.07%
210,812
+27,774
+15% +$648K
USG
309
DELISTED
Usg
USG
$4.27M 0.07%
+100,000
New +$4.28M
SCHW
310
Charles Schwab
SCHW
$180B
$4.26M 0.07%
102,683
+101
+0.1% +$4.57K
KMB icon
311
Kimberly-Clark
KMB
$36.8B
$4.25M 0.07%
37,267
-2,926
-7% -$325K
ZTS icon
312
Zoetis
ZTS
$32.2B
$4.25M 0.07%
49,634
+1,947
+4% +$175K
WAB icon
313
Wabtec
WAB
$49.9B
$4.17M 0.06%
+59,433
New +$5.19M
RMD icon
314
ResMed
RMD
$29.4B
$4.16M 0.06%
36,570
+28,504
+353% +$3.05M
DVN icon
315
Devon Energy
DVN
$50.7B
$4.15M 0.06%
184,298
+83,678
+83% +$2.57M
ICE icon
316
Intercontinental Exchange
ICE
$83.5B
$4.09M 0.06%
54,369
-477
-0.9% -$36.6K
PKG icon
317
Packaging Corp of America
PKG
$22.4B
$4.06M 0.06%
48,607
+7,975
+20% +$742K
HALO icon
318
Halozyme
HALO
$9.71B
$4.05M 0.06%
277,000
+117,000
+73% +$1.87M
GWPH
319
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.01M 0.06%
41,200
+4,580
+13% +$601K
WRK
320
DELISTED
WestRock Company
WRK
$3.97M 0.06%
105,219
+43,270
+70% +$1.91M
GBT
321
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.94M 0.06%
96,000
-68,000
-41% -$2.55M
NSC icon
322
Norfolk Southern
NSC
$77.4B
$3.92M 0.06%
26,237
-295
-1% -$48.5K
PHM icon
323
Pultegroup
PHM
$24.6B
$3.92M 0.06%
150,799
+106,183
+238% +$2.63M
HUBB icon
324
Hubbell
HUBB
$25.4B
$3.89M 0.06%
+39,192
New +$4.3M
VEEV icon
325
Veeva Systems
VEEV
$31.6B
$3.89M 0.06%
43,566
+9,066
+26% +$828K
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.